More Americans are getting tested for colon cancer and breast cancer, the U.S. Centers for Disease Control (CDC) recently reported, but the numbers still aren’t high enough.
Browsing: Uncategorized
Researchers in California may have discovered new drug targets to treat an incurable hereditary disease that leads to loss of motor coordination, dementia and death.
The Company is a biopharmaceutical company that has established a diverse drug development platform to actualize therapeutics indicated for the treatment of cancer and neuropathic pain.
The company is a specialty biopharmaceutical company that utilizes an immunology-based drug development platform to actualize therapeutics indicated for cancer and autoimmune disease. The company’s …
The company is a medical devices company that has developed a novel therapeutic technology for the treatment of prostate cancer. The company’s apparatus uses non-invasive MRI imaging to identify prostate cell masses, and a trans-urethral ultrasound applicator …
The latest issue of the New Companies & Technologies Report (NCTR) has been published on innovative companies and technologies in health and medicine. * If you are not a subscriber to the Intelligence Services and wish to receive full access to all company information listed below please visit: onemedplace.com/nctr. In this issue we profile innovation in the following areas (by keywords): 1. AML Remission Maintenance 2. Monoclonal Antibody Therapeutics 3. Prostate Cancer 4. Nitric Oxide Synthase Inhibitor Therapeutics 5. Hormone Contraceptives
The information could allow researchers to observe cellular changes as a patient undergoes cancer treatment, and could aid in the development of new molecular therapeutics for diseases such as cancer.
An experimental drug from Nektar Therapeutics was able to shrink tumors and reduce a cancer biomarker in women with advanced ovarian cancer in a mid-stage study.